Kerber, R., Till, J.E., Simon, S.L., Lyon, J.L., Thomas, D.C., Preston-Martin, S., Rallison, M. L., Lloyd, R.D., Stevens, W. A Cohort Study of Thyroid Disease in Relation to Fallout from Nuclear Weapons Testing. JAMA 270, 2076–2082. 1993.


Lyon, J., Klauber, M.R., Gardner, J., and Udall, K. Childhood Leukemias Associated with Fallout from Nuclear Testing. New Engl. J. Med. 300, 397–402. 1979.


Maxon, H.R., Saenger, E.L., Thomas, S.R., Buncher, C.R., Kereiakes, J.G., Shafer, M.L., and McLaughlin, C.A. Clinically Important Radiation-Associated Thyroid Disease. A Controlled Study. JAMA 244, 1802–1805. 1980.


Nagataki, S., Shibata, Y., Inoue, S., Yokoyama, N., Izumi, M., and Shimaoka, K. Thyroid Diseases among Atomic Bomb Survivors in Nagasaki. J. Am. Med. Assoc. 272, 364–370. 1994.

NCI (National Cancer Institute). Estimated Exposures and Thyroid Doses Received by the American People from Iodine-131 in the Fallout Following Nevada Atmospheric Nuclear Bomb Tests. National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Washington, DC. 1997.

NCRP (National Council on Radiation Protection and Measurements). Principles and Application of Collective Dose in Radiation Protection. NCRP Report No. 121, NCRP, Bethesda, MD. 1995.

NCRP (National Council on Radiation Protection and Measurements). Recommended Screening Limits for Contaminated Surface Soil and Review of Factors Relevant to Site-Specific Studies. NCRP Report No. 129, NCRP, Bethesda, MD. 1999.

Ng, Y.C., Anspaugh, L.R., and Cederwall, R.T. ORERP (Off-Site Radiation Exposure Review Project) Internal Dose Estimates for Individuals. Health Phys. 59, 693–710. 1990.


Pierce, D.A., Shimizu, Y., Preston, D.L., Vaeth, M., and Mabuchi, K. Studies of the Mortality of Atomic Bomb Survivors. Report 12, Part I. Cancer: 1950–1990. Radiat. Res. 146, 1– 27. 1996.

Pillai, N.K., Thangavelu, M., and Ramalingaswami, V. Nodular Lesions of the Thyroid in an Area of High Background Radiation in Coastal Kerala, India. Indian J. Med. Res. 64, 537–544. 1976.

Pottern, L.M., Kaplan, M.M., Larsen, P.R., Silva, J.E., Koenig, R.J., Lubin, J.H., Stovall, M., and Boice, J.D. Thyroid Nodularity after Childhood Irradiation for Lymphoid Hyperplasia: A Comparison of Questionnaire and Clinical Findings. J. Clin. Epidemiol. 43, 449–460. 1990.

Pottern, L.M., Stone, B.J., Day, N.E., Pickle, L.W., and Fraumeni, J.F. Thyroid Cancer in Connecticut, 1935–1975: An Analysis by Cell Type. Am. J. Epidemiol. 112, 764–774. 1980.

Preston D.L., Kusumi S., Tomonaga M., Izumi, S., Ron, E., Kuramoto, A., Kamada, N., Dohy, H., Matsuo, T., Nonaka, H., Thompson, D.E., Soda, M., and Mabuchi, K. Cancer Incidence in Atomic Bomb Survivors. Part III. Leukemia, Lymphoma, and Multiple Myeloma . Radiat. Res., 137, S68–S97. 1994.


Rallison, M.L., Lotz, T.M., Bishop, M., Divine, W., Haywood, K., Lyon, J.L., and Stevens, W. Cohort Study of Thyroid Diseases near the Nevada Test Site: A Preliminary Report. Health Phys. 59, 739–746. 1990.

Roesch, W.G. (Ed.) US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Final Report. Volume 1. Hiroshima, Japan: Radiation Effects Research Foundation. 1987.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement